BDBM50222840 3-(cyclopropylmethyl)-N,N,4-trimethyl-2-(3-(trifluoromethyl)benzamido)-2,3-dihydrothiazole-5-carboxamide::CHEMBL248202
SMILES: CN(C)C(=O)c1s\c(=N/C(=O)c2cccc(c2)C(F)(F)F)n(CC2CC2)c1C
InChI Key: InChIKey=OEVHQALCNZSKAN-NKFKGCMQSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM50222840 (3-(cyclopropylmethyl)-N,N,4-trimethyl-2-(3-(triflu...) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | Article PubMed | n/a | n/a | 1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Taisho Pharmaceutical Co. Ltd Curated by ChEMBL | Assay Description Displacement of [3H]CP-55940 form human CB2 receptor expressed in CHO cells | Bioorg Med Chem Lett 17: 6299-304 (2007) Article DOI: 10.1016/j.bmcl.2007.09.004 BindingDB Entry DOI: 10.7270/Q2PG1SJQ | |||||||||||
More data for this Ligand-Target Pair |